Update on therapy for acute and chronic heart failure. Applying advances in outpatient management.
Care of patients with heart failure is often challenging and involves proper therapeutic selection from the pharmacologic, interventional, and mechanical options available. In this article, Drs Almeda and Hollenberg discuss the latest approaches and guidelines to treatment of acute and chronic heart failure in patients with left ventricular systolic dysfunction. They review the benefits, risks, and myriad considerations that physicians need to assess before making choices about best medical management.
Almeda
Francis Q
FQ
Rush-Presbyterian-St Luke's Medical Center, Jelke Pavillon, Suite 1021, 1653 W Congress Pkwy, Chicago, IL 60612, USA. francis_q_almeda@rush.edu
Hollenberg
Steven M
SM
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000553:Ambulatory Care; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000145:classification / Q000503:physiopathology / Q000628:therapy*; D006353:Heart-Assist Devices; D006801:Humans; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D014665:Vasodilator Agents